Ameriprise
KYTH

Ameriprise’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Ameriprise’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-82,038
Closed -$6.15M – 4028
2015
Q3 		$6.15M Buy
82,038
+73,508
+862% +$5.49M ﹤0.01% 1860
2015
Q2 		$642K Buy
+8,530
New +$457K ﹤0.01% 3331
2015
Q1 		– Sell
-10,530
Closed -$365K – 3989
2014
Q4 		$365K Sell
10,530
-14,036
-57% -$490K ﹤0.01% 3252
2014
Q3 		$805K Sell
24,566
-11,847
-33% -$417K ﹤0.01% 2888
2014
Q2 		$1.4M Buy
36,413
+3,617
+11% +$126K ﹤0.01% 2664
2014
Q1 		$1.3M Sell
32,796
-135,728
-81% -$6.07M ﹤0.01% 2630
2013
Q4 		$6.28M Buy
168,524
+142,786
+555% +$5.92M ﹤0.01% 1849
2013
Q3 		$1.18M Buy
25,738
+25,102
+3,947% +$751K ﹤0.01% 2634
2013
Q2 		$17K Buy
+636
New +$14.6K ﹤0.01% 4411

Ameriprise's KYTH Position: Q4 2015 in Review

Ameriprise sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 82,038 shares — an estimated $6.15M sold.

Ameriprise first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $6.28M in Q4 2013. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Ameriprise reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Ameriprise sold 82,038 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.15M.
  • Ameriprise first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
  • Ameriprise's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.28M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Ameriprise's 13F filing for Q4 2015, filed 11 Feb 2016.